Skip to main content
Search

# Tensor decomposition

2 related articles

Subscribe to updates
  1. arXiv

    Mouse tumor drug screens need not be run in full: GrAFT-PDX couples growth and death in one model and can stop losing combinations early

    Patient-derived xenografts (PDX) implant human tumors into immunocompromised mice to test drugs, but screening every tumor-drug combination is infeasible in time and cost. GrAFT-PDX is a Bayesian model that jointly models tumor growth trajectories and mouse death risk, using a low-rank tensor decomposition to share information across PDX lines, treatments and time, so it can impute untested experiments and predict death times. On the large PDXe screen it assigns higher log probability to death times than Royston-Parmar and other survival baselines, matches strong baselines on tumor response, and preserves known gene-drug associations without genomic input.

  2. bioRxiv

    Neuralign puts neural recordings from different sessions into one tensor decomposition, sharing a time course while estimating trial and neuron weights per session

    Neuralign places neural recordings from different sessions and animals, with different sampled neurons, into one tensor decomposition in which each component shares a single temporal curve while trial strength and neuron weights are estimated per session, so no matched neurons or matched trials are needed. On 93 brain-wide recordings from 19 mice, an unsupervised fit yielded a single component that separated the three anterior lateral motor cortex (ALM) optogenetic inhibition conditions, with balanced accuracy of 0.647 on held-out sessions against a chance level of 1/3. That component's change showed a modest association with the drop in behavioural accuracy (ρ = 0.266 over 180 session–inhibition observations).

You’re all caught up